HemaSphere (Jun 2022)
PB1835: THE ISTH-DIC SCORE PREDICTS 30-DAYS OUTCOME IN NON-M3 ACUTE MYELOID LEUKEMIA PATIENTS
- G. Paterno,
- R. Palmieri,
- V. Forte,
- F. Bonanni,
- L. Guarnera,
- F. Mallegni,
- M. R. Pascala,
- B. Elisa,
- F. Moretti,
- A. Savi,
- L. Maurillo,
- F. Buccisano,
- A. Venditti,
- M. I. Del Principe
Affiliations
- G. Paterno
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- R. Palmieri
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- V. Forte
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- F. Bonanni
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- L. Guarnera
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- F. Mallegni
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- M. R. Pascala
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- B. Elisa
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- F. Moretti
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- A. Savi
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- L. Maurillo
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- F. Buccisano
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- A. Venditti
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- M. I. Del Principe
- 1 Department of Biomedicine and Prevention, Tor Vergata University, Rome, Italy
- DOI
- https://doi.org/10.1097/01.HS9.0000850192.01228.bc
- Journal volume & issue
-
Vol. 6
pp. 1715 – 1716
Abstract
No abstracts available.